Search

everythinglearnresearchcommunity

for

Search:↓

Some leukemia treatments can cause skin reactions similar to keratosis pilaris.

Androgens increase growth factors in skin cells, which may lead to acne.

Targeting the HEDGEHOG-GLI1 pathway could help treat keloids.

SOX2 helps reduce wound size and pressure ulcer formation by suppressing oxidative stress and increasing antioxidant activity in mice.

Lenvatinib and sorafenib are generally safe but need dose adjustments due to side effects.

The Wnt/β-catenin pathway helps tissue regeneration but can also cause fibrosis, and drugs that inhibit this pathway may aid in healing skin and heart tissues.

Adding dutasteride to therapy may improve treatment for advanced salivary duct cancer.

Dapagliflozin improved blood sugar control in a man with Werner syndrome without side effects.

NSC167409 can effectively inhibit the virus causing hand, foot, and mouth disease.

Trastuzumab may cause tufted hair folliculitis as a side effect.

Overexpressing the epigen gene in mice leads to enlarged sebaceous glands and greasy fur.

Early intervention and tailored management are crucial for skin side effects in cancer treatments.

A girl with lupus had unusually long and thick eyelashes, a rare symptom of her condition.

TGF-alpha affects skin thickness, hair growth, and may contribute to psoriasis and papilloma formation.

YAP and TAZ are crucial for skin cell growth and repair.

Tideglusib helps heal wounds in older skin.

GLI1 might protect against the start of skin cancer and is not linked to cancer severity.

Hejie Shengfa Decoction may help treat alopecia areata by promoting hair growth and reducing inflammation, but more safety studies are needed.

Triphenylphosphine oxide can increase oil production and reduce inflammation in skin cells without affecting TRPM5.

Removing Lrig1-positive cells in mice leads to temporary loss of sebaceous glands.

Tyrosine kinases are important in skin autoimmune diseases and could be targets for new treatments.

Reduced EGFR signaling delays hair cycle and reduces fat growth, but hair development remains normal.

miR-200c-3p could help diagnose and treat alopecia areata.

Nilotinib can cause generalized keratosis pilaris.

Some drugs can cause permanent hair loss, though it's rare.

A protein called desmoglein 3 is important for keeping hair follicle stem cells inactive and helps in their regeneration.

Modern skin cancer treatments can cause skin side effects and hair loss, affecting patients' quality of life.

EGFR signaling is crucial for skin and hair health, and targeting it could help treat skin diseases and cancer.

Specific immune cells and pathways contribute to hair follicle inflammation and hair loss, suggesting potential treatments for lichen planopilaris.

An 84-year-old man developed a rare scalp condition from a cancer drug but continued treatment as it was otherwise well tolerated.